Form 4 holding
Chief Commercial Officer
Crinetics Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 29,259
- Estimated value
- $1,289,737
- Report date
- 05 Jul 2024
- Price
- $44.08
- Ownership
- Direct
James Hassard - Chief Commercial Officer at Crinetics Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Chief Commercial Officer
- Issuer symbol
- CRNX on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
SEC evidence
1 source field
No buys or sells have been reported by James Hassard since 02 Jun 2025
Reported holdings for James Hassard in Crinetics Pharmaceuticals, Inc.
Form 4 holding
Chief Commercial Officer
Crinetics Pharmaceuticals, Inc.
- Security class
- Stock option (Right to Buy)
- Shares / value
- 130,000
- Estimated value
- Report date
- 05 Jul 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for James Hassard in Crinetics Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.